Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_1223 |
Primary information | |
---|---|
B3PDB ID | b3pdb_1223 |
Peptide Name | D-penetratin |
PEPTIDE SEQUENCE (1-letter) | RQIKIWFQNRRMKWKK |
PEPTIDE SEQUENCE (3-letter) | NA |
N-terminal modification | NA |
C-terminal modification | NA |
Chemical modification | NA |
Peptide Length | 16 |
Conformation | NA |
Peptide Nature | NA |
Source/Origin of peptide | Chemically synthesized |
SMILES | NA |
Cell Line | In situ brain perfusion technique |
In vitro CONCENTRATION | NA |
In vitro METHOD | Capillary depletion method |
In vitro RESULT | Vectorization of dox led to a 20-fold increase in the amount of dox transportation. |
ANIMAL MODEL | Male Sprague-Dawley rats |
In vivo CONCENTRATION | 2.5 mg/kg |
In vivo MODE OF DELIVERY | Intravenous |
In vivo METHOD | Capillary depletion method |
In vivo RESULT | It led to a significant increase in brain dox concentrations during the first 30 min of postadminist |
ACTION | The use of these peptide vectors for brain delivery of dox. |
TRANSPORT TYPE | Transcytosis |
SUBCELLULAR LOCALISATION | Brain parenchyma |
COMBINATION | Combined with Doxorubicin |
PHYSICAL CONDITION | NA |
RESPONSE | NA |
RESULT | NA |
LABEL | NA |
PMID | 10727512 |